# NCT04417660 (NCT04417660)

> Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

No report yet. It can be ordered.

- Drugs tested: bintrafusp alfa
- Indication: thymoma and thymic carcinoma

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04417660
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: Thymic Epithelial Tumor; Recurrent Thymoma; Thymic Cancer
- Interventions: M7824
- Enrollment: 9
- Primary outcome: Objective response rate

## Indexed commentary on NCT04417660 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct04417660